Literature DB >> 17188611

Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis.

Philip T Nowicki1, Donna A Caniano, Sue Hammond, Peter J Giannone, Gail E Besner, Kristina M Reber, Craig A Nankervis.   

Abstract

OBJECTIVE: To determine the expression and function of endothelial nitric oxide synthase (eNOS) in submucosal arterioles harvested from human intestine resected for necrotizing enterocolitis (NEC) or congenital bowel disease. STUDY
DESIGN: eNOS expression was determined by using immunohistochemistry. The arteriolar diameter was measured in vitro at pressures of 10 to 40 mm Hg and also in response to the eNOS agonist acetylcholine (ACh), the exogenous nitric oxide (NO) donor S-nitroso-N-acetylpenicillamine, and the smooth muscle relaxant papaverine. Arteriolar release of NO in response to ACh was determined with a Sievers NOAnalyzer. Hemodynamics were also determined at flow rates of 50 and 100 microL/min.
RESULTS: eNOS was present in microvessels from both groups, but NEC arterioles failed to demonstrate physiological evidence of eNOS function: they constricted in response to pressure, failed to dilate or generate NO in response to ACh, and failed to dilate in response to flow. However, they dilated in response to exogenous NO and papaverine, indicating functional vascular smooth muscle and vasodilator reserve.
CONCLUSION: eNOS-derived NO, a vasodilator in the newborn intestine, did not contribute to vasoregulation in arterioles harvested from intestine resected for NEC. These vessels were constricted; lack of eNOS-derived NO may contribute to this vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17188611     DOI: 10.1016/j.jpeds.2006.09.029

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

Review 1.  Novel treatments for NEC: keeping IBD in mind.

Authors:  Sanjiv Harpavat; Mohan Pammi; Mark Gilger
Journal:  Curr Gastroenterol Rep       Date:  2012-10

Review 2.  Analytical chemistry of nitric oxide.

Authors:  Evan M Hetrick; Mark H Schoenfisch
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2009       Impact factor: 10.745

Review 3.  Endothelium-dependent control of vascular tone during early postnatal and juvenile growth.

Authors:  Matthew A Boegehold
Journal:  Microcirculation       Date:  2010-07       Impact factor: 2.628

4.  Lack of VEGFR2 signaling causes maldevelopment of the intestinal microvasculature and facilitates necrotizing enterocolitis in neonatal mice.

Authors:  Xiaocai Yan; Elizabeth Managlia; Shirley Xl Liu; Xiao-Di Tan; Xiao Wang; Catherine Marek; Isabelle G De Plaen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-25       Impact factor: 4.052

Review 5.  The role of the intestinal microcirculation in necrotizing enterocolitis.

Authors:  Daniel J Watkins; Gail E Besner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

Review 6.  The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis.

Authors:  Nikunj K Chokshi; Yigit S Guner; Catherine J Hunter; Jeffrey S Upperman; Anatoly Grishin; Henri R Ford
Journal:  Semin Perinatol       Date:  2008-04       Impact factor: 3.300

Review 7.  Enteral Feeding Interventions in the Prevention of Necrotizing Enterocolitis: A Systematic Review of Experimental and Clinical Studies.

Authors:  Ilse H de Lange; Charlotte van Gorp; Laurens D Eeftinck Schattenkerk; Wim G van Gemert; Joep P M Derikx; Tim G A M Wolfs
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

8.  Mesenteric nitric oxide and superoxide production in experimental necrotizing enterocolitis.

Authors:  Jill S Whitehouse; Hao Xu; Yang Shi; LeAnne Noll; Sushma Kaul; Deron W Jones; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay
Journal:  J Surg Res       Date:  2009-08-19       Impact factor: 2.192

Review 9.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

10.  Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects.

Authors:  Jixin Yang; Yanwei Su; Yu Zhou; Gail E Besner
Journal:  Pathophysiology       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.